Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology
Immunity - United States
doi 10.1016/j.immuni.2018.12.014
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Elsevier BV